150 related articles for article (PubMed ID: 25410816)
1. FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities.
Iqbal WS; Chan KL
J Pharm Sci; 2015 Jan; 104(1):280-4. PubMed ID: 25410816
[TBL] [Abstract][Full Text] [Related]
2. FTIR spectroscopic imaging of dissolution of a solid dispersion of nifedipine in poly(ethylene glycol).
Chan KL; Kazarian SG
Mol Pharm; 2004; 1(4):331-5. PubMed ID: 15981592
[TBL] [Abstract][Full Text] [Related]
3. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
4. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
[TBL] [Abstract][Full Text] [Related]
5. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
6. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging.
Ewing AV; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2014 Aug; 60():64-71. PubMed ID: 24832964
[TBL] [Abstract][Full Text] [Related]
7. Solid-state characterization of nifedipine solid dispersions.
Vippagunta SR; Maul KA; Tallavajhala S; Grant DJ
Int J Pharm; 2002 Apr; 236(1-2):111-23. PubMed ID: 11891075
[TBL] [Abstract][Full Text] [Related]
8. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
9. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
[TBL] [Abstract][Full Text] [Related]
11. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
Kushida I; Gotoda M
Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
[TBL] [Abstract][Full Text] [Related]
12. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
13. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
14. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
15. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
Wlodarski K; Sawicki W; Kozyra A; Tajber L
Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
[TBL] [Abstract][Full Text] [Related]
16. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
[TBL] [Abstract][Full Text] [Related]
17. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
18. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
19. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
Marsac PJ; Konno H; Rumondor AC; Taylor LS
Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of a solid phase reaction among excipients that accelerates drug release from a solid dispersion with aging.
Mizuno M; Hirakura Y; Yamane I; Miyanishi H; Yokota S; Hattori M; Kajiyama A
Int J Pharm; 2005 Nov; 305(1-2):37-51. PubMed ID: 16226411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
